- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Hepatic Glycogen
Total 3355 results
-
H. Lundbeck A/SCompleted
-
Duke UniversityKriya TherapeuticsRecruitingGlycogen Storage Disease VI | GLYCOGEN STORAGE DISEASE IXa1 | GLYCOGEN STORAGE DISEASE IXa2 | Glycogen Storage Disease IXB | Glycogen Storage Disease IXC | GSD 9 (All Subtypes) | GSD 6United States
-
Per Bendix JeppesenAarhus University Hospital; University of AarhusUnknown
-
United States Army Research Institute of Environmental...Completed
-
Moscow Regional Research and Clinical Institute...TerminatedGlycogen Synthase Kinase 3Russian Federation
-
University Medical Center GroningenUltragenyx Pharmaceutical IncCompletedGlycogen Storage Disease Type IANetherlands
-
John MitchellCompletedGlycogen Storage Disease Type III | Glycogen Storage Disease Type IA | Glycogen Storage Disease Type IB | Glycogen Storage Disease Type 0Canada
-
Ultragenyx Pharmaceutical IncCompletedGlycogen Storage Disease Type IANetherlands, United States
-
Rigshospitalet, DenmarkUnknownCarbohydrate Metabolism, Inborn Errors | Metabolism, Inborn Errors | Lipid Metabolism, Inborn Errors | Glycogen Storage Disease Type II | Glycogen Storage Disease Type V | VLCAD Deficiency | Glycogen Storage Disease Type III | Phosphoglycerate Kinase Deficiency | Neutral Lipid Storage Disease | Carnitine... and other conditionsDenmark
-
CENTOGENE GmbH RostockWithdrawnFructose Metabolism, Inborn Errors | Glycogen Storage Disease Type II | Glycogen Storage Disease | Glycogen Storage Disease Type V | Glycogen Storage Disease Type I | Glycogen Storage Disease Type III | Glycogen Storage Disease Type VII | Glycogen Storage Disease Type IV | Glycogen Storage Disease Type... and other conditionsGermany, India, Sri Lanka
-
Helga EllingsgaardCompletedGlycogen DepletionDenmark
-
Ultragenyx Pharmaceutical IncActive, not recruitingGlycogen Storage Disease Type IAUnited States, Brazil, Canada, Denmark, Germany, Italy, Netherlands, Spain
-
Ultragenyx Pharmaceutical IncActive, not recruitingGlycogen Storage Disease Type IA | Von Gierke's Disease (GSD Type Ia)Netherlands, United States, Canada, Spain
-
Javier Gonzalez, PhDMaastricht University; University of Newcastle Upon-Tyne; Sugar Nutrition, UKCompletedLiver and Muscle Glycogen Use During Exercise.United Kingdom
-
Sanguine BiosciencesTerminatedGlycogen Storage Disease Type IBUnited States
-
Xinhua Hospital, Shanghai Jiao Tong University...Recruiting
-
Northumbria UniversityNewcastle University; Maastricht University; Sugar NutritionCompletedLiver and Muscle Glycogen Replenishment Post-exerciseUnited Kingdom
-
University of ManitobaCo-Investigator - Dr. Cheryl Rockman-GreenbergCompletedHypoglycemia | Glycogen Storage Disorder Type 1 | Cornstarch | GlycosadeCanada
-
Dongguan HEC TaiGen Biopharmaceuticals Co., Ltd.Peking University People's HospitalCompletedCirrhosis | Chronic Hepatics C Virus (HCV) Genotype 1 | Non-Cirrhotic | Treatment naïveChina
-
Maastricht University Medical CenterUnknownCarbohydrate Oxidation and Glycogen Utilization During and Following ExerciseNetherlands
-
Baylor Research InstituteUltragenyx Pharmaceutical IncCompletedAdult Polyglucosan Body Disease | Glycogen Brancher Enzyme Deficiency | Glycogen Storage Disease Type IVFrance
-
Novartis PharmaceuticalsCompletedNormal Hepatic Function | Impaired Hepatic FunctionUnited States
-
Novartis PharmaceuticalsCompletedNormal Hepatic Function | Impaired Hepatic FunctionBelgium, Germany, Israel, Bulgaria, United States
-
Novartis PharmaceuticalsCompletedNormal Hepatic Function | Impaired Hepatic FunctionUnited States
-
GlycoMimetics IncorporatedCompletedModerate Hepatic Impairment | Normal Hepatic FunctionUnited States
-
Astellas Pharma Europe B.V.Medivation, Inc.CompletedSevere Hepatic Impairment | Normal Hepatic FunctionBulgaria
-
PfizerCompletedMild Hepatic Dysfunction | Moderate Hepatic DysfunctionSouth Africa
-
Hong Kong Children's HospitalRecruitingPortal Vein | Hepatic Veins | Hepatic Artery | Liver CirculationHong Kong
-
PfizerRecruitingHealthy Volunteers | Moderate Hepatic Impairment | Severe Hepatic ImpairmentUnited States
-
Nicoline LøkkenCompleted
-
University Medical Center GroningenUniversity of Oxford; University of the Faroe Islands; Stichting Stofwisselkracht and other collaboratorsCompleted
-
Rigshospitalet, DenmarkCompleted
-
Areeg El-GharbawyUltragenyx Pharmaceutical IncCompletedGlycogen Storage Disease Type IUnited States
-
Institut National de la Santé Et de la Recherche...Rigshospitalet, DenmarkUnknownGlycogen Storage Disease Type V
-
Hospital de Clinicas de Porto AlegreConselho Nacional de Desenvolvimento Científico e Tecnológico; Fundação Médica...CompletedGlycogen Storage Disease Type IBrazil
-
Assistance Publique - Hôpitaux de ParisUnknownFulminating Hepatic FailureFrance
-
Rigshospitalet, DenmarkUniversity College, LondonCompletedMcArdle DiseaseDenmark, United Kingdom
-
Reneo Pharma LtdCompletedMcArdle DiseaseSpain, United Kingdom
-
IRCCS Eugenio MedeaUniversity of Pisa; University of MessinaCompleted
-
Rigshospitalet, DenmarkCompleted
-
Duke UniversityCompleted
-
University of FloridaPrometheus LaboratoriesCompletedInflammatory Bowel Disease | Glycogen Storage Disease Type IaUnited States
-
Eisai Inc.CompletedHepatic Impairment | Hepatic FunctionUnited States
-
Rigshospitalet, DenmarkCompletedGlycogen Storage Disease Type IIIDenmark
-
University of ZurichCompletedGlycogen Storage Disease Type 1 (GSD 1)Switzerland
-
Rigshospitalet, DenmarkCompleted
-
Vital Therapies, Inc.CompletedFulminant Hepatic FailureUnited States
-
Vital Therapies, Inc.WithdrawnFulminant Hepatic FailureUnited States
-
Agios Pharmaceuticals, Inc.CompletedModerate Hepatic ImpairmentUnited States